Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

Published Date: 06 Sep 2024

Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5%

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New policy review highlights the importance of health-related quality of life in advanced cancer

2.

'Personalized' Approach to RT for Bladder Cancer Promising but Challenging

3.

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

4.

Early Tislelizumab May Boost PFS in Esophageal Cancer

5.

No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot